An increasing share of commitments are being earmarked for GP-led transactions over the course of 2025, data from investment bank Lazard has found. GP-led transactions accounted for 48 percent of the ...
• Blackstone’s global head of life sciences, Nicholas Galakatos, talked to PE Hub Europe about a “new era of medicine” • GP-led secondaries deals like continuation funds surged through the second half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results